R

Roberto Giugliani

Universidade Federal do Rio Grande do Sul

ORCID: 0000-0001-9655-3686

1.4k papers and 25k citations.

PubIndex Score98Top 2%How it's scored

1.4kPublications

25kTotal Citations

First senior author: 1987

Top publicationsby citations

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Raphael Schiffmann, Derralynn Hughes et al.|New England Journal of Medicine|2016

Cited by 555

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

Paul Harmatz, Stuart J. Swiedler, Roberto Giugliani et al.|The Journal of Pediatrics|2006

Cited by 364

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

Elizabeth Braunlin, Roberto Giugliani, Paul Harmatz et al.|Journal of Inherited Metabolic Disease|2011

Cited by 302

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

Paul Harmatz, Celeste Decker, Michael Beck et al.|Molecular Genetics and Metabolism|2008

Cited by 216

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study

Christian J. Hendriksz, Wolfgang Dummer, Barbara K. Burton et al.|Journal of Inherited Metabolic Disease|2014

Cited by 211

Indexing the rest of 1,415 publications…